Optimized Extract - Optimized Fear Extinction Research
HDAC-OX Scientifically Engineered HDAC Class I Inhibitor (HDAC-C1I) Extract
Indications for anxiolytic, fear extinction, analgesia, and antidepressant research (potental for anti-aging research).
Warning: Last items in stock!
HDAC-OX Guided Scientifically Engineered HDAC Class I Inhibitor (HDAC-C1I) Extract
Source: Contractually proprietary
Antidepressant, Anxiolytic, and Fear Extinction Capacity:
Research within murine assays displayed significant fear extinction, anxiolytic, and antidepressant effects within a dose range of 6-12mg/kg p.o. as once daily administration within chow.
Assays with animal analgesia models displayed moderate analgesia in various models as well as significant analgesic-sparing capacity when administered concurrently with opioid agonists.
Displays significant antitumor activity in vitro and in vivo against a broad spectrum of murine and human tumor models. Selectivity, potency, and efficacy demonstrated to be within comparable equivalence to Acetyldinaline (CI-994) as a reference standard.
Theorized Potential Anti Aging and Tleomerase Activating Capacity:
Furthermore, notable rapid and pronounced signs reflective of an "anti-aging" nature were demonstrated. These are theorized to be from promoting significant telomerase activation, reflective of such potentials known within this class, including for example tichostatin A.
Theoretical Human Usage Dosing Correlations:
Extrapolation from animal data indicates potential effective dosing protocols to be within the range of 50-100mg q.d.. Such would potentially be theorized to be best within administrations of 3-7 consecutive days with washouts equal to or twoce the period of usage.
USAGE: For Research Use Only! Not For Use in Humans.